NCT02109900

Brief Summary

This observational study aims the potential role of serum progesterone levels on the day of oocyte pick-up on the probability of pregnancy, in patients undergoing antagonist IVF cycles. There has been evidence, that increased serum levels of progesterone on triggering day are associated with a decreased probability of pregnancy after IVF. There is no study that investigate assocation between serum progesterone levels on the day of oocyte pick-up and IVF outcomes. This study will be the first in this case.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 7, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 10, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Last Updated

April 10, 2014

Status Verified

April 1, 2014

Enrollment Period

4 months

First QC Date

April 7, 2014

Last Update Submit

April 8, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical pregnancy

    Clinical pregnancy, defined as ultrasound evidence of gestational sac at 6 weeks of gestation

    At 6-8 weeks of gestation

Study Arms (1)

Serum Progesteron Levels

Other: Serum Progesterone Levels

Interventions

Serum Progesteron Levels

Eligibility Criteria

Age18 Years - 39 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Patients who are referred to Acibadem Kayseri Hospital IVF Unit

You may qualify if:

  • Age \< 40 years
  • Basal FSH \< 12 IU/L
  • Basal P \< 1.6 ng/mL

You may not qualify if:

  • Women with polycystic ovaries syndrome (PCOS)
  • Women with Stage III-IV Endometriosis
  • Women with a pathological condition of the adrenal glands

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Turgut Aydin

    Acıbadem Kayseri Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist, Gynecology and Obstetrics

Study Record Dates

First Submitted

April 7, 2014

First Posted

April 10, 2014

Study Start

February 1, 2014

Primary Completion

June 1, 2014

Last Updated

April 10, 2014

Record last verified: 2014-04